TP53 and osteosarcoma: This disease model is potentiated by the loss of Rb1 (p53/Rb1 DKO: Osx-cre; p53lox/lox; Rb1lox/lox), recapitulating the negative impact of RB1 mutations in human osteosarcoma [28].